Purpose is to identify whether immune markerscan predict success of salvage anti-retroviral therapy.
Over the last several years two markers of disease have been utilized to determine if antiretroviral therapy has been successful, one is a CD4 cell count (reflects the immunocompetence of an infected individual) and a HIV viral load (a blood test used to determine the amount of HIV in the infected individual). However in patients who fail their first line of therapythe likelihood of extended resuppressing viral replication with subsequent therapies may be as low as 25-50%. This information may take several months to determine the new therapies possible continuing success. It would be preferable to have additional markers that respond to therapies in the first several weeks to such therapies, therfore possibly offering patients alternate treatment earlier without potentiatinglong term side effects and possible further drug resistance.
Study Type
OBSERVATIONAL
Enrollment
50
McMaster Health Science Center
Hamilton, Ontario, Canada
The Ottawa Hospital
Ottawa, Ontario, Canada
Maple Leaf Clinic
Toronto, Ontario, Canada
Unnamed facility
Toronto, Ontario, Canada
Windsor Regional Hospital
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Windsor, Ontario, Canada